As of Feb 17
| +0.02 / +0.07%|
The 26 analysts offering 12-month price forecasts for Roche have a median target of 34.72, with a high estimate of 43.81 and a low estimate of 28.97. The median estimate represents a +13.72% increase from the last price of 30.53.
The current consensus among 27 polled investment analysts is to Buy stock in Roche. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.